Clinical Trial Update: Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating conditioning regimens for allogeneic hematopoietic stem-cell transplantation has completed recruitment with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Anemia Hemolytic
• Acquired Neutropenia in Newborn
• Acquired Thrombocytopenia
• Adrenoleukodystrophy
• Bone Marrow Failure Syndrome
• Combined Immunodeficiency
• Common Variable Immunodeficiency
• Diamond-blackfan Anemia
• Granulomatous Disease
• Hemophagocytic Lymphohistiocytoses
• Hurler Syndrome
• Mannosidosis
• Sickle Cell Disease
• Thalassemia
• Wiskott-aldrich Syndrome
• X-linked Lymphoproliferative Disease

Snippet

Sponsor: University of Florida | Conditions: Bone Marrow Failure Syndrome, Thalassemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-15